Published in Biochemistry on April 01, 1967
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Metabolism of adenosine 3',5'-cyclic monophosphate and induction of fruiting bodies in Coprinus macrorhizus. J Bacteriol (1973) 1.41
The specific interaction of cibacron and related dyes with cyclic nucleotide phosphodiesterase and lactate dehydrogenase. Biochem J (1978) 1.41
Bovine cone photoreceptor cGMP phosphodiesterase structure deduced from a cDNA clone. Proc Natl Acad Sci U S A (1990) 1.24
The actions of dibutyryl cyclic adenosine 3',5'-monophosphate and methyl xanthines on pancreatic exocrine secretion. J Physiol (1972) 1.23
Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline. J Clin Invest (1973) 1.20
Cyclic adenosine 3',5'-monophosphate concentration in the pancreas following stimulation by secretin, cholecystokinin-pancreozymin and acetylcholine. J Physiol (1972) 1.14
Effects of catecholamines and their interaction with other hormones on cyclic 3',5'-adenosine monophosphate of the kidney. J Clin Invest (1972) 1.12
Current recording from sensory cilia of olfactory receptor cells in situ. I. The neuronal response to cyclic nucleotides. J Gen Physiol (1991) 1.12
3':5'-cyclic adenosine monophosphate phosphodiesterase: negative cooperativity. Proc Natl Acad Sci U S A (1972) 1.05
Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone. J Clin Invest (1976) 1.05
Evidence against the presence of 3',5'-cyclic adenosine monophosphate and relevant enzymes in Lactobacillus plantarum. J Bacteriol (1972) 0.96
Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone. J Clin Invest (1974) 0.94
Effects of acetazolamide on the urinary excretion of cyclic AMP and on the activity of renal adenyl cyclase. J Clin Invest (1974) 0.92
Function of calmodulin in postsynaptic densities. I. Presence of a calmodulin-activatable cyclic nucleotide phosphodiesterase activity. J Cell Biol (1981) 0.91
Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia. J Clin Invest (1974) 0.89
Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br J Pharmacol (1982) 0.86
Stimulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) activity by low concentrations of circulating glucose in perfused rat liver. Biochem J (1975) 0.83
The relation of adenyl cyclase to the activity of other ATP utilizing enzymes and phosphodiesterase in preparations of rat brain; mechanism of stimulation of cyclic AMP accumulation by NaF. Br J Pharmacol (1973) 0.82
The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons. J Surg Res (1980) 0.81
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase. Biochem J (1970) 0.80
Effects of magnesium on cyclic GMP hydrolysis by the bovine retinal rod cyclic GMP phosphodiesterase. Biochem J (1995) 0.78
The role of 3':5'-cyclic nucleotide phosphodiesterase in regulating tissue concentrations of adenosine 3':5'-cyclic mooophosphate. Biochem J (1970) 0.78
Lasting biological effects of early environmental influences. VII. Metabolism of adenosine in mice exposed to early environmental stress. J Exp Med (1972) 0.78
Cyclic adenosine 3', 5'-monophosphate in cerebrospinal fluid during thermoregulation and fever. J Physiol (1976) 0.77
Studies on the mechanism of action of glucagon in strips of rabbit renal artery. Br J Pharmacol (1980) 0.76
Effect of buffer composition on binding of adenosine 3':5'-cyclic monophosphate by bovine adrenal extracts. Biochem J (1977) 0.75
The actions of prostaglandins E 1 and F 2 on the on the perfused vessels of the isolated rabbit ear. Br J Pharmacol (1972) 0.75
Adenyl cyclase system and cerebral energy state. J Neurol Neurosurg Psychiatry (1976) 0.75
Calmodulin plays a pivotal role in cellular regulation. Science (1980) 8.20
Cyclic 3',5'-nucleotide phosphodiesterase. Demonstration of an activator. Biochem Biophys Res Commun (1970) 3.18
Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ (2000) 3.12
Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator. J Biol Chem (1971) 2.55
Dark and photometabolism of sugars by a blue green alga: Tolypothrix tenuis. Plant Physiol (1966) 2.18
Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase. Biochem Biophys Res Commun (1975) 2.04
Cyclic 3':5'-nucleotide phosphodiesterase. Purification, characterization, and active form of the protein activator from bovine brain. J Biol Chem (1974) 1.83
Immunocytochemical localization of calmodulin and a heat-labile calmodulin-binding protein (CaM-BP80) in basal ganglia of mouse brain. J Cell Biol (1980) 1.78
Activation of calmodulin by various metal cations as a function of ionic radius. Mol Pharmacol (1984) 1.77
Calmodulin stimulates human platelet phospholipase A2. Biochem Biophys Res Commun (1979) 1.62
Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment. Health Technol Assess (2003) 1.56
Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation. J Plast Reconstr Aesthet Surg (2009) 1.55
Assessment of the proximal femoral morphology using plain radiograph-can it predict the bone quality? J Arthroplasty (2006) 1.54
Human erythrocyte Ca2+-Mg2+-ATPase: mechanism of stimulation by Ca2+. Arch Biochem Biophys (1979) 1.39
Inhibition of cyclic nucleotide phosphodiesterase by adenosine 5'triphosphate and inorganic pyrophosphate. Biochem Biophys Res Commun (1966) 1.38
Towards primary care for non-serious 999 callers: results of a controlled study of "Treat and Refer" protocols for ambulance crews. Qual Saf Health Care (2004) 1.33
Cyclic 3',5'-nucleotide phosphodiesterase. Distribution and developmental changes of the enzyme and its protein activator in mammalian tissues and cells. Biochim Biophys Acta (1974) 1.31
Cyclic 3'.5'-nucleotide phosphodiesterase. Effect of binding protein on the hydrolysis of cyclic AMP. Biochem Biophys Res Commun (1972) 1.30
Case-control study of the health of those looked after by local authorities. Arch Dis Child (2001) 1.29
Practice characteristics associated with audit activity: a medical audit advisory group survey. Br J Gen Pract (1994) 1.28
Purification and characterization of an inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase. J Biol Chem (1979) 1.27
Assay of calmodulin by Ca2+-dependent phosphodiesterase. Methods Enzymol (1983) 1.20
Calmodulin activates NAD kinase of sea urchin eggs: an early event of fertilization. Cell (1981) 1.19
Calmodulin: an overview. Fed Proc (1982) 1.18
Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids. Proc Natl Acad Sci U S A (1985) 1.18
An endogenous Ca2+-dependent activator protein of brain adenylate cyclase and cyclic neucleotide phosphodiesterase. Adv Cyclic Nucleotide Res (1978) 1.15
A prospective study of pyogenic sepsis of the hip in childhood. J Bone Joint Surg Br (2007) 1.10
Induction training, career counselling, and performance review: views of junior medical staff. Postgrad Med J (1998) 1.09
Objective evaluation of ERCP procedures: a simple grading scale for evaluating technical difficulty. Postgrad Med J (2003) 1.09
Calcineurin is a calmodulin-dependent protein phosphatase. Biochem Biophys Res Commun (1982) 1.07
Localization of calmodulin in rat tissues. Proc Natl Acad Sci U S A (1980) 1.07
A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy (2003) 1.07
Calmodulin. Production of an antibody in rabbit and development of a radioimmunoassay. J Biol Chem (1979) 1.07
Ca++-dependent formation of brain adenylate cyclase-protein activator complex. Biochem Biophys Res Commun (1976) 1.06
High levels of a heat-labile calmodulin-binding protein (CaM-BP80) in bovine neostriatum. Biochemistry (1980) 1.06
Calmodulin: its potential role in cell proliferation and heavy metal toxicity. Fed Proc (1984) 1.06
An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase. Arch Biochem Biophys (1978) 1.04
Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics. J Biol Chem (1976) 1.04
Marked increase of human platelet phospholipase A2 activity in vitro and demonstration of an endogenous inhibitor. Proc Natl Acad Sci U S A (1983) 1.01
Rat brain adenylate cyclase. Further studies on its stimulation by a Ca2+-binding protein. Arch Biochem Biophys (1977) 1.01
Glycolytic control mechanisms. V. Kinetics of high energy phosphate intermediate changes during electrical discharge and recovery in the main organ of Electrophorus electricus. J Biol Chem (1967) 1.00
Cyclic 3':5'-nucleotide phosphodiesterase. Stimulation of bovine brain cytoplasmic enzyme by lysophosphatidylcholine. J Biol Chem (1977) 1.00
Pragmatic randomised trial to evaluate the use of patient held records for the continuing care of patients with cancer. Qual Health Care (2001) 0.99
Calcium binding domains of calmodulin. Sequence of fill as determined with terbium luminescence. J Biol Chem (1982) 0.97
Calmodulin-dependent protein phosphatase: a developmental study. Biochemistry (1983) 0.96
Kinetics of cyclic adenosine monophosphate changes in rat heart following epinephrine administration. Nature (1965) 0.93
Catalytic site of calmodulin-dependent protein phosphatase from bovine brain resides in subunit A. Proc Natl Acad Sci U S A (1984) 0.93
Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis (2000) 0.92
Cyclic 3',5'-nucleotide phosphodiesterase Ca++-dependent formation of bovine brain enzyme-activator complex. FEBS Lett (1975) 0.91
Bovine brain calmodulin-dependent protein phosphatase. Regulation of subunit A activity by calmodulin and subunit B. J Biol Chem (1985) 0.91
Substrate-specific forms of human platelet phospholipase A2. J Biol Chem (1986) 0.90
Coupling between sagittal and frontal plane deformity correction in idiopathic thoracic scoliosis and its relationship with postoperative sagittal alignment. Spine (Phila Pa 1976) (2010) 0.89
Activation of bovine brain calmodulin-dependent protein phosphatase by limited trypsinization. Biochemistry (1984) 0.89
Purification and characterization of a protein activator of cyclic nucleotide phosphodiesterase from bovine brain. Methods Enzymol (1974) 0.89
Glycolytic control mechanisms. IV. Kinetics of glycolytic intermediate changes during electrical discharge and recovery in the main organ of Electrophorus electricus. J Biol Chem (1967) 0.88
Purification and characterization of cyclic 3',5'-nucleotide phosphodiesterase from bovine brain. Methods Enzymol (1974) 0.88
Calmodulin. Sci Am (1982) 0.88
Underestimation of cyclic 3',5'-nucleotide phosphodiesterase activity by a radioisotopic assay using an anionic-exchange resin. Anal Biochem (1975) 0.87
Cyclic 3',5'-nucleotide phosphodiesterase. Preparation of a partially inactive enzyme and its subsequent stimulation by snake venom. Biochim Biophys Acta (1969) 0.87
Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator. J Biol Chem (1976) 0.86
Surgical treatment of recalcitrant radiation-induced gastric erosions. Head Neck (2000) 0.86
Multifunctional role of calmodulin in biologic processes. Cold Spring Harb Symp Quant Biol (1982) 0.86
Characterization of bovine brain calmodulin-dependent protein phosphatase. Arch Biochem Biophys (1984) 0.84
Purification and radioimmunoassay of calmodulin-dependent protein phosphatase from bovine brain. Methods Enzymol (1983) 0.84
Stimulation of calmodulin by cadmium ion. Arch Toxicol (1985) 0.84
Brain L-glutamate decarboxylase. Inhibition by phosphorylation and activation by dephosphorylation. J Biol Chem (1995) 0.84
Identification of quantitative trait loci for resistance against Verticillium longisporum in oilseed rape (Brassica napus). Phytopathology (2008) 0.84
Brevibacterium liquefaciens adenylate cyclase and its in vivo stimulation by pyruvate. J Bacteriol (1975) 0.83
Adenylate cyclase of Brevibacterium liquefaciens. Inactivation by neuraminidase, phospholipase A and phospholipase C. Biochem Biophys Res Commun (1973) 0.83
A spectrofluorimetric assay of calmodulin-dependent protein phosphatase using 4-methylumbelliferyl phosphate. Anal Biochem (1986) 0.83
Stimulation of myosin light-chain kinase by Cd2+ and Pb2+. Arch Toxicol (1995) 0.83
Adenosine 3',5'-monophosphate: on its mechanism of action. Perspect Biol Med (1972) 0.82
Cyclic 3 ', 5 '-nucleotide phosphodiesterase. Effect of divalent cations. Biochim Biophys Acta (1971) 0.82
Clinical guidelines online: do they improve compliance? Postgrad Med J (2004) 0.82
Calmodulin and calcium channel blockers. Hypertension (1987) 0.81
Formation of cis-14,15-oxido-5,8,11-icosatrienoic acid from phosphatidylinositol in human platelets. Proc Natl Acad Sci U S A (1987) 0.81
The role of calmodulin in prostaglandin metabolism. Ann N Y Acad Sci (1980) 0.81
Calmodulin and the adenylate cyclase-phosphodiesterase system. Cell Calcium (1981) 0.81
Right hip adduction deficit and adolescent idiopathic scoliosis. J Orthop Surg (Hong Kong) (2008) 0.81
Predicting the risk of cardiovascular comorbidities in adult cancer survivors. Curr Oncol (2013) 0.80
The structure and regulation of phosphoglucose isomerase in Saccharomyces cerevisiae. Mol Gen Genet (1988) 0.80
Calmodulin-dependent enzymes undergo a protein-induced conformational change that is associated with their interactions with calmodulin. J Biol Chem (1994) 0.80
Phylogeny analysis of 25 apple rootstocks using RAPD markers and tactical gene tagging. Theor Appl Genet (1994) 0.79
Immunisation status in the public care system: a comparative study. Vaccine (2005) 0.79
Activation of troponin C by Cd2+ and Pb2+. Arch Toxicol (1990) 0.79
Immunocytochemical localization of calmodulin in regions of rodent brain. Ann N Y Acad Sci (1980) 0.79
Cyclic 3',5'-nucleotide phosphodiesterase. A continous titrimetric assay. Anal Biochem (1969) 0.78
Quantitative subcellular localization of calmodulin-dependent phosphatase in chick forebrain. J Neurosci (1988) 0.78
Calmodulin-dependent protein phosphatase: immunocytochemical localization in chick retina. J Cell Biol (1985) 0.78
Differential reactivities of lysines in calmodulin complexed to phosphatase. J Biol Chem (1987) 0.77
Cyclic 3',5'-nucleotide phosphodiesterase: localization and latent activity in rat brain. Nature (1967) 0.77
Purification and characterization of calmodulin from porcine renal medulla. Arch Biochem Biophys (1980) 0.77
Nucleotide cyclases. Prog Nucleic Acid Res Mol Biol (1982) 0.77
Immunofluorescent localization of cGMP, cGMP-dependent protein kinase, calmodulin and cAMP in the rat uterus. Effects of estrogen treatment. Cell Tissue Res (1983) 0.77
Subunit A of calmodulin-dependent protein phosphatase requires Mn2+ for activity. Biochem Biophys Res Commun (1984) 0.76
Calmodulin-dependent protein phosphatase: isolation of subunits and reconstitution to holoenzyme. Methods Enzymol (1987) 0.76
H+ is involved in the activation of calcineurin by calmodulin. J Biol Chem (1994) 0.76
Biological functions of calmodulin. Harvey Lect (1986) 0.76
cAMP renders Ca2+-dependent phosphodiesterase refractory to inhibition by a calmodulin-binding protein (calcineurin). J Biol Chem (1981) 0.76